Effectiveness of BNT162b2 vaccine against the B.1.1.7 variant of SARS-CoV-2 among healthcare workers in Brescia, Italy.

Sansone, E; Tiraboschi, M; Sala, E; Albini, E; Lombardo, M; Castelli, F; De Palma, G

Sansone, E; Tiraboschi, M; Sala, E; Albini, E; Lombardo, M; Castelli, F; De Palma, G.

Sansone E; Unit of Occupational Health and Industrial Hygiene, DSMC, University of Brescia, Brescia, Italy.
Tiraboschi M; Unit of Occupational Health and Industrial Hygiene, DSMC, University of Brescia, Brescia, Italy.
Sala E; Unit of Occupational Health, Hygiene, Toxicology and Prevention, ASST Spedali Civili, 25123, Brescia, Italy.
Albini E; Unit of Occupational Health, Hygiene, Toxicology and Prevention, ASST Spedali Civili, 25123, Brescia, Italy.
Lombardo M; Chief Executive Office, ASST Spedali Civili di Brescia, Brescia, Italy.
Castelli F; University Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili, 25123 Brescia, Italy.
De Palma G; Unit of Occupational Health and Industrial Hygiene, DSMC, University of Brescia, Brescia, Italy; Unit of Occupational Health, Hygiene, Toxicology and Prevention, ASST Spedali Civili, 25123, Brescia, Italy. Electronic address: giuseppe.depalma@unibs.it.

J Infect ; 83(1): e17-e18, 2021 Jul.

Article in English | MEDLINE | ID: covidwho-1219933

Subject(s)

COVID-19; Vaccines; BNT162 Vaccine; COVID-19 Vaccines; Health Personnel; Humans; Italy/epidemiology; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Experimental Studies / Observational study Topics: Vaccines / Variants Limits: Humans Country/Region as subject: Europa Language: English Journal: J Infect Year: 2021 Document Type: Article Affiliation country: J.jinf.2021.04.038

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google